ATI RN
ATI Pharmocology Exam Fletcher NRSG 106 Questions
Extract:
Question 1 of 5
A nurse is caring for a client who has schizophrenia and is taking haloperidol. The nurse should monitor for which of the following adverse effects of haloperidol?
Correct Answer: D
Rationale: The correct answer is D: Extrapyramidal symptoms. Haloperidol is a first-generation antipsychotic known to cause extrapyramidal symptoms such as dystonia, akathisia, parkinsonism, and tardive dyskinesia. Monitoring for these adverse effects is crucial as they can impact the client's quality of life and adherence to treatment. Fever (
A), intractable hiccups (
B), and excessive salivation (
C) are not common adverse effects of haloperidol. Extrapyramidal symptoms are a well-documented side effect of this medication, making option D the most appropriate choice for the nurse to monitor in this case.
Question 2 of 5
The nurse is reviewing herbal therapies. Which is a common use of the herb feverfew?
Correct Answer: A
Rationale: The correct answer is A: Menstrual cramps. Feverfew is commonly used to alleviate menstrual cramps due to its anti-inflammatory and antispasmodic properties. It helps reduce uterine contractions and relieve pain associated with menstruation.
Choices B, C, and D are incorrect as feverfew is not typically used for constipation, muscle aches, or incision pain after surgery. Feverfew is mainly known for its effectiveness in menstrual-related issues.
Question 3 of 5
When a patient is taking an adrenergic agonist drug, the nurse expects to observe which effect?
Correct Answer: B
Rationale: The correct answer is B: Increased heart rate. Adrenergic agonist drugs stimulate the sympathetic nervous system, leading to effects such as increased heart rate due to activation of beta-adrenergic receptors on the heart. Constricted pupils (
Choice
A) are associated with cholinergic agonist drugs. Bronchial constriction (
Choice
C) is not expected with adrenergic agonists, as they typically cause bronchodilation. Increased GI peristalsis (
Choice
D) is also not a common effect of adrenergic agonists, as they tend to reduce GI motility.
Question 4 of 5
A 6-year-old boy has been started on an extended-release form of methylphenidate hydrochloride for the treatment of attention deficit hyperactivity disorder (ADHD). During a follow-up visit, his mother tells the nurse that she has been giving the medication at bedtime so that it will be 'in his system' when he goes to school the next morning. What is the nurse's appropriate evaluation of the mother's actions?
Correct Answer: A
Rationale: The correct answer is A. Methylphenidate hydrochloride is a stimulant medication commonly used for ADHD. Giving the extended-release form of the medication at bedtime can lead to difficulty falling asleep due to its stimulating effects. By giving the last dose 4 to 6 hours before bedtime, the stimulant effects will diminish, allowing the child to fall asleep more easily.
Choice B is incorrect because taking the medication with meals does not impact its absorption significantly.
Choice C is incorrect because withholding the medication until he is at school would not be beneficial for managing his symptoms throughout the day.
Choice D is incorrect because giving the medication at bedtime is not appropriate due to the risk of insomnia.
Question 5 of 5
When evaluating a patient who is taking orlistat, which is an intended therapeutic effect?
Correct Answer: A
Rationale: The correct answer is A: Decreased weight. Orlistat is a weight-loss medication that works by inhibiting the absorption of dietary fats. This leads to reduced calorie intake and ultimately results in weight loss. Increased appetite (
B) would be an unintended effect as orlistat is meant to decrease appetite by promoting a feeling of fullness. Decreased hyperactivity (
C) and increased wakefulness (
D) are not associated with orlistat use.